The secreted inhibitor of invasive cell growth CREG1 is negatively regulated by cathepsin proteases
Open Access
- 8 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cellular and Molecular Life Sciences
- Vol. 78 (2), 733-755
- https://doi.org/10.1007/s00018-020-03528-5
Abstract
Previous clinical and experimental evidence strongly supports a breast cancer-promoting function of the lysosomal protease cathepsin B. However, the cathepsin B-dependent molecular pathways are not completely understood. Here, we studied the cathepsin-mediated secretome changes in the context of the MMTV-PyMT breast cancer mouse model. Employing the cell-conditioned media from tumor-macrophage co-cultures, as well as tumor interstitial fluid obtained by a novel strategy from PyMT mice with differential cathepsin B expression, we identified an important proteolytic and lysosomal signature, highlighting the importance of this organelle and these enzymes in the tumor micro-environment. The Cellular Repressor of E1A Stimulated Genes 1 (CREG1), a secreted endolysosomal glycoprotein, displayed reduced abundance upon over-expression of cathepsin B as well as increased abundance upon cathepsin B deletion or inhibition. Moreover, it was cleaved by cathepsin B in vitro. CREG1 reportedly could act as tumor suppressor. We show that treatment of PyMT tumor cells with recombinant CREG1 reduced proliferation, migration, and invasion; whereas, the opposite was observed with reduced CREG1 expression. This was further validated in vivo by orthotopic transplantation. Our study highlights CREG1 as a key player in tumor–stroma interaction and suggests that cathepsin B sustains malignant cell behavior by reducing the levels of the growth suppressor CREG1 in the tumor microenvironment.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (SFB 850 B7, RE1584/6-2)
- Deutschen Konsortium für Translationale Krebsforschung (L627)
- Excellence Initiative of the German federal and state governments (EXC 294, BIOSS B10)
This publication has 106 references indexed in Scilit:
- Nanoporous CREG-Eluting Stent Attenuates In-Stent Neointimal Formation in Porcine Coronary ArteriesPLOS ONE, 2013
- hLGDB: a database of human lysosomal genes and their regulationDatabase: The Journal of Biological Databases and Curation, 2013
- A cross-platform toolkit for mass spectrometry and proteomicsNature Biotechnology, 2012
- iProphet: Multi-level Integrative Analysis of Shotgun Proteomic Data Improves Peptide and Protein Identification Rates and Error EstimatesMolecular & Cellular Proteomics, 2011
- Integrated Proteomic Profiling of Cell Line Conditioned Media and Pancreatic Juice for the Identification of Pancreatic Cancer BiomarkersMolecular & Cellular Proteomics, 2011
- Reversed‐phase chromatography with multiple fraction concatenation strategy for proteome profiling of human MCF10A cellsProteomics, 2011
- Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in miceProceedings of the National Academy of Sciences of the United States of America, 2010
- MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantificationNature Biotechnology, 2008
- UniProt: the Universal Protein knowledgebaseNucleic Acids Research, 2004
- Empirical Statistical Model To Estimate the Accuracy of Peptide Identifications Made by MS/MS and Database SearchAnalytical Chemistry, 2002